Report Detail

Pharma & Healthcare Global Pneumococcal Vaccines Market Research Report 2020, Forecast to 2025

  • RnM4235315
  • |
  • 28 October, 2020
  • |
  • Global
  • |
  • 176 Pages
  • |
  • Multimarket Insight
  • |
  • Pharma & Healthcare

The report forecast global Pneumococcal Vaccines market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period of 2020-2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. Estimates of the regional markets for Pneumococcal Vaccines are based on the applications market.

The report demonstrates detail coverage of Pneumococcal Vaccines industry and main market trends.
The market research includes historical and forecast data, like demand, application details, price trends, and company shares of the leading Pneumococcal Vaccines by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Since the COVID-19 virus outbreak in December 2019, the World Health Organization declared it a public health emergency. The desease has spread to over 100 countries and caused huge losses of lives around the globe. Especially the global manufacturing, tourism and financial markets have been hit hard. The downward pressure on the world economy that once showed signs of recovery in the previous period has increased again. The outbreak of the epidemic has added risk factors to the already weak growth of the world economy. Many international organizations have pointed out that the world economy is in the most severe period since the financial crisis.
The negative global impacts of the coronavirus are already there, significantly affecting the Pneumococcal Vaccines market in 2020. This report studies and analyzes the in-depth impact of Coronavirus COVID-19 on the Pneumococcal Vaccines industry.
In addition, the report provides insight into main drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Pneumococcal Vaccines market are discussed. And this report covers the historical situation, present status and the future prospects of the global Pneumococcal Vaccines market for 2015-2025.

Market Segment by Product Type
PPSV 23
PCV 7/13
PCV 10

Market Segment by Product Application
For Infants
For Children (2-10)
For Person (10-64)
For The Old (≥65)

Finally, the report provides detailed profile and data information analysis of leading company.
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac

Report Includes:
- xx data tables (appendix tables)
- Overview of global Pneumococcal Vaccines market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Pneumococcal Vaccines market
- Profiles of major players in the industry, including Pfizer, Sanofi, GSK, Merck, Eli Lilly.....

Research Objectives
1.To study and analyze the global Pneumococcal Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
2.To understand the structure of Pneumococcal Vaccines market by identifying its various subsegments.
3.Focuses on the key global Pneumococcal Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Pneumococcal Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Pneumococcal Vaccines submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    Global Pneumococcal Vaccines Market Research Report 2020, Forecast to 2025

      1 Market Overview

      • 1.1 Pneumococcal Vaccines Definition
        • 1.1.1 Analysis of Macroeconomic Indicators
        • 1.1.2 Years Considered
      • 1.2 Pneumococcal Vaccines Segment by Type
        • 1.2.1 PPSV 23
        • 1.2.2 PCV 7/13
        • 1.2.3 PCV 10
      • 1.3 Market Analysis by Application
        • 1.3.1 For Infants
        • 1.3.2 For Children (2-10)
        • 1.3.3 For Person (10-64)
        • 1.3.4 For The Old (≥65)
      • 1.4 Overview of Global Pneumococcal Vaccines Market
        • 1.4.1 Global Pneumococcal Vaccines Revenue (2015-2025)
        • 1.4.2 Global Pneumococcal Vaccines Production and Capacity (2015-2025)
        • 1.4.3 North America Pneumococcal Vaccines Status and Prospect (2015-2025)
        • 1.4.4 Europe Pneumococcal Vaccines Status and Prospect (2015-2025)
        • 1.4.5 Japan Pneumococcal Vaccines Status and Prospect (2014-2025)
        • 1.4.6 China Pneumococcal Vaccines Status and Prospect (2015-2025)
      • 1.5 Market Dynamics
        • 1.5.1 Market Opportunities
        • 1.5.2 Market Risk
        • 1.5.3 Market Driving Force
        • 1.5.4 Porter's Five Forces Analysis
        • 1.5.5 SWOT Analysis
      • 1.6 Coronavirus Disease 2019 (Covid-19): Pneumococcal Vaccines Industry Impact
        • 1.6.1 How the Covid-19 is Affecting the Pneumococcal Vaccines Industry
        • 1.6.2 Pneumococcal Vaccines Business Impact Assessment - Covid-19
        • 1.6.3 Market Trends and Pneumococcal Vaccines Potential Opportunities in the COVID-19 Landscape
        • 1.6.4 Measures / Proposal against Covid-19

      2 Global Pneumococcal Vaccines Market Competition by Manufacturer

      • 2.1 Global Pneumococcal Vaccines Sales and Market Share by Manufacturer (2018-2020)
      • 2.2 Global Pneumococcal Vaccines Revenue and Market Share by Manufacturer (2018-2020)
      • 2.3 Global Pneumococcal Vaccines Industry Concentration Ratio (CR5 and HHI)
      • 2.4 Top 5 Pneumococcal Vaccines Manufacturer Market Share
      • 2.5 Top 10 Pneumococcal Vaccines Manufacturer Market Share
      • 2.6 Date of Key Manufacturers Enter into Pneumococcal Vaccines Market
      • 2.7 Key Manufacturers Pneumococcal Vaccines Product Offered
      • 2.8 Mergers & Acquisitions Planning

      3 Analysis of Pneumococcal Vaccines Industry Key Manufacturers

      • 3.1 Pfizer
        • 3.1.1 Company Details
        • 3.1.2 Product Information
        • 3.1.3 Pfizer Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.1.4 Main Business Overview
        • 3.1.5 Pfizer News
      • 3.2 Sanofi
        • 3.2.1 Company Details
        • 3.2.2 Product Information
        • 3.2.3 Sanofi Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.2.4 Main Business Overview
        • 3.2.5 Sanofi News
      • 3.3 GSK
        • 3.3.1 Company Details
        • 3.3.2 Product Information
        • 3.3.3 GSK Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.3.4 Main Business Overview
        • 3.3.5 GSK News
      • 3.4 Merck
        • 3.4.1 Company Details
        • 3.4.2 Product Information
        • 3.4.3 Merck Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.4.4 Main Business Overview
        • 3.4.5 Merck News
      • 3.5 Eli Lilly
        • 3.5.1 Company Details
        • 3.5.2 Product Information
        • 3.5.3 Eli Lilly Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.5.4 Main Business Overview
        • 3.5.5 Eli Lilly News
      • 3.6 AstraZeneca
        • 3.6.1 Company Details
        • 3.6.2 Product Information
        • 3.6.3 AstraZeneca Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.6.4 Main Business Overview
        • 3.6.5 AstraZeneca News
      • 3.7 Abera
        • 3.7.1 Company Details
        • 3.7.2 Product Information
        • 3.7.3 Abera Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.7.4 Main Business Overview
        • 3.7.5 Abera News
      • 3.8 S K Chemicals
        • 3.8.1 Company Details
        • 3.8.2 Product Information
        • 3.8.3 S K Chemicals Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.8.4 Main Business Overview
        • 3.8.5 S K Chemicals News
      • 3.9 Beijing Minhai Biotechnology
        • 3.9.1 Company Details
        • 3.9.2 Product Information
        • 3.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.9.4 Main Business Overview
        • 3.9.5 Beijing Minhai Biotechnology News
      • 3.10 Baxter
        • 3.10.1 Company Details
        • 3.10.2 Product Information
        • 3.10.3 Baxter Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.10.4 Main Business Overview
        • 3.10.5 Baxter News
      • 3.11 Biken
        • 3.11.1 Company Details
        • 3.11.2 Product Information
        • 3.11.3 Biken Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.11.4 Main Business Overview
        • 3.11.5 Biken News
      • 3.12 Celgene Corporation
        • 3.12.1 Company Details
        • 3.12.2 Product Information
        • 3.12.3 Celgene Corporation Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.12.4 Main Business Overview
        • 3.12.5 Celgene Corporation News
      • 3.13 Panacea Biotec
        • 3.13.1 Company Details
        • 3.13.2 Product Information
        • 3.13.3 Panacea Biotec Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.13.4 Main Business Overview
        • 3.13.5 Panacea Biotec News
      • 3.14 Serum Institute of India
        • 3.14.1 Company Details
        • 3.14.2 Product Information
        • 3.14.3 Serum Institute of India Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.14.4 Main Business Overview
        • 3.14.5 Serum Institute of India News
      • 3.15 Genentech
        • 3.15.1 Company Details
        • 3.15.2 Product Information
        • 3.15.3 Genentech Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.15.4 Main Business Overview
        • 3.15.5 Genentech News
      • 3.16 Genocea Biosciences
        • 3.16.1 Company Details
        • 3.16.2 Product Information
        • 3.16.3 Genocea Biosciences Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.16.4 Main Business Overview
        • 3.16.5 Genocea Biosciences News
      • 3.17 ImmunoBiology
        • 3.17.1 Company Details
        • 3.17.2 Product Information
        • 3.17.3 ImmunoBiology Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.17.4 Main Business Overview
        • 3.17.5 ImmunoBiology News
      • 3.18 Lupin
        • 3.18.1 Company Details
        • 3.18.2 Product Information
        • 3.18.3 Lupin Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.18.4 Main Business Overview
        • 3.18.5 Lupin News
      • 3.19 Nuron Biotech
        • 3.19.1 Company Details
        • 3.19.2 Product Information
        • 3.19.3 Nuron Biotech Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.19.4 Main Business Overview
        • 3.19.5 Nuron Biotech News
      • 3.20 Biogen
        • 3.20.1 Company Details
        • 3.20.2 Product Information
        • 3.20.3 Biogen Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.20.4 Main Business Overview
        • 3.20.5 Biogen News
      • 3.21 Valneva Austria
        • 3.21.1 Company Details
        • 3.21.2 Product Information
        • 3.21.3 Valneva Austria Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.21.4 Main Business Overview
        • 3.21.5 Valneva Austria News
      • 3.22 Sinovac
        • 3.22.1 Company Details
        • 3.22.2 Product Information
        • 3.22.3 Sinovac Pneumococcal Vaccines Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.22.4 Main Business Overview
        • 3.22.5 Sinovac News

      4 Global Pneumococcal Vaccines Market Size Categorized by Regions (2015-2020)

      • 4.1 Global Pneumococcal Vaccines Sales Market Share by Region
      • 4.2 Global Pneumococcal Vaccines Revenue Market Share by Region (2015-2019)
      • 4.3 Global Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.4 North America Pneumococcal Vaccines Market Size Detail
        • 4.4.1 North America Pneumococcal Vaccines Sales Growth Rate (2015-2020)
        • 4.4.2 North America Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.5 Europe Pneumococcal Vaccines Market Size Detail
        • 4.5.1 Europe Pneumococcal Vaccines Sales Growth Rate (2015-2020)
        • 4.5.2 Europe Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.6 Japan Pneumococcal Vaccines Market Size Detail
        • 4.6.1 Japan Pneumococcal Vaccines Sales Growth Rate (2015-2020)
        • 4.6.2 Japan Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.7 China Pneumococcal Vaccines Market Size Detail
        • 4.7.1 China Pneumococcal Vaccines Sales Growth Rate (2015-2020)
        • 4.7.2 China Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2015-2020)

      5 Global Pneumococcal Vaccines Market Segment by Type

      • 5.1 Global Pneumococcal Vaccines Revenue, Sales and Market Share by Type (2015-2020)
        • 5.1.1 Global Pneumococcal Vaccines Sales and Market Share by Type (2015-2020)
        • 5.1.2 Global Pneumococcal Vaccines Revenue and Market Share by Type (2015-2020)
      • 5.2 PPSV 23 Sales Growth Rate and Price
        • 5.2.1 Global PPSV 23 Sales Growth Rate (2015-2020)
        • 5.2.2 Global PPSV 23 Price (2015-2020)
      • 5.3 PCV 7/13 Sales Growth Rate and Price
        • 5.3.1 Global PCV 7/13 Sales Growth Rate (2015-2020)
        • 5.3.2 Global PCV 7/13 Price (2015-2020)
      • 5.4 PCV 10 Sales Growth Rate and Price
        • 5.4.1 Global PCV 10 Sales Growth Rate (2015-2020)
        • 5.4.2 Global PCV 10 Price (2015-2020)

      6 Global Pneumococcal Vaccines Market Segment by Application

      • 6.1 Global Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
      • 6.2 For Infants Sales Growth Rate (2015-2020)
      • 6.3 For Children (2-10) Sales Growth Rate (2015-2020)
      • 6.4 For Person (10-64) Sales Growth Rate (2015-2020)
      • 6.5 For The Old (≥65) Sales Growth Rate (2015-2020)

      7 Pneumococcal Vaccines Related Market Analysis

      • 7.1 Upstream Analysis
        • 7.1.1 Macro Analysis of Upstream Markets
        • 7.1.2 Key Players in Upstream Markets
        • 7.1.3 Upstream Market Trend Analysis
        • 7.1.4 Pneumococcal Vaccines Manufacturing Cost Analysis
      • 7.2 Downstream Market Analysis
        • 7.2.1 Macro Analysis of Down Markets
        • 7.2.2 Key Players in Down Markets
        • 7.2.3 Downstream Market Trend Analysis
        • 7.2.4 Sales Channel, Distributors, Traders and Dealers

      8 Global Pneumococcal Vaccines Market Forecast

      • 8.1 Global Pneumococcal Vaccines Sales, Revenue Forecast
        • 8.1.1 Global Pneumococcal Vaccines Sales Growth Rate Forecast (2020-2025)
        • 8.1.2 Global Pneumococcal Vaccines Revenue and Growth Rate Forecast (2020-2025)
        • 8.1.3 Global Pneumococcal Vaccines Price and Trend Forecast (2020-2025)
      • 8.2 Global Pneumococcal Vaccines Sales Forecast by Region (2020-2025)
        • 8.2.1 North America Pneumococcal Vaccines Sales, Revenue Forecast (2020-2025)
        • 8.2.2 Europe Pneumococcal Vaccines Sales, Revenue Forecast (2020-2025)
        • 8.2.3 Japan Pneumococcal Vaccines Production, Revenue Forecast (2020-2025)
        • 8.2.4 China Pneumococcal Vaccines Production, Revenue Forecast (2020-2025)

      9 Research Findings and Conclusion

        10 Appendix

        Summary:
        Get latest Market Research Reports on Pneumococcal Vaccines. Industry analysis & Market Report on Pneumococcal Vaccines is a syndicated market report, published as Global Pneumococcal Vaccines Market Research Report 2020, Forecast to 2025. It is complete Research Study and Industry Analysis of Pneumococcal Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,680.00
        $4,200.00
        2,119.88
        3,322.20
        2,470.96
        3,872.40
        416,204.00
        652,260.00
        223,780.00
        350,700.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report